The Neurology Minute® podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD, FAAN, with contributions by experts from the Neurology® journals, Neurology Today®, Continuum®, and more.
Neurology, psychiatry, rehabilitation and medical-education teams get a concise update on functional neurological disorder as a common, legitimate neurological condition. Positive rule-in clinical features, a coherent brain-based explanation, non-stigmatising language and shared multidisciplinary teaching support earlier diagnosis and clearer patient communication.
Neurology, ophthalmology and rheumatology teams get a mechanism-first review of overlapping brain, retinal, auditory and mucosal syndromes. Susac syndrome is framed as a brain-retina-inner-ear microangiopathy, while atypical Behçet presentations require review for viral lesions, monogenic inflammatory disorders and other biological mimics before targeted immunotherapy.
Neurology, psychiatry and emergency clinicians get a trauma-informed perspective on migraine among post-9/11 veterans. Military sexual trauma is associated with greater migraine burden, emergency headache attendance and opioid exposure, making permission-based enquiry, pain-comorbidity review and interdisciplinary psychological support relevant to refractory presentations.
Neurology clinicians assessing rapidly progressive dementia get a concise diagnostic update. Human prion disease should be classified as sporadic, genetic or acquired, with CSF RT-QUIC, correct polypropylene sample tubes, MRI and EEG interpretation, family history and active exclusion of treatable mimics kept within the same pathway.
Neurology clinicians, educators and service leaders get a systems-focused update on workforce advocacy, public brain-health education and academic leadership. Action alerts, professional meetings and leadership forums are connected to specialist access, research capacity and international collaboration.
Neurology, genetics and primary-care teams get a service-planning update on asymptomatic ALS risk-variant carriers. Wider testing, gene-targeted therapies, neurofilament light chain biomarkers and prevention trials are making carrier status increasingly actionable, with implications for counselling, surveillance, family planning, trial access and specialist clinic capacity.
Neurology and geriatric teams get a focused appraisal of acetazolamide for idiopathic normal pressure hydrocephalus. Despite changes on MRI, the drug does not improve gait, cognition, quality of life or overall symptoms and causes more treatment discontinuation, reinforcing the priority of specialist shunt assessment.
Neurology, emergency medicine and critical-appraisal readers get a compact update on blood-based phosphorylated tau-217, adjunctive tirofiban after thrombolysis and thrombectomy, and artificial intelligence in peer review. The clinical thread is careful interpretation: promising biomarkers and trial signals do not yet justify stand-alone diagnosis or automatic practice change.
Emergency, acute medicine and neurology clinicians get a concise framework for separating primary from secondary headache. Abrupt onset, pattern change, systemic disease, abnormal neurology, precipitating activities and pregnancy or postpartum status are balanced against reassuring features such as longstanding recurrent attacks, symptom-free intervals and family history.
Paediatric neurology and adolescent-health teams get a concise transition-care update. Planning should begin years before transfer, using structured tools, care binders, documented responsibilities and institution-specific solutions to reduce gaps between paediatric and adult epilepsy services.
.svg)